Pittsburgh plasma p-tau217: classification accuracies for autosomal dominant and sporadic Alzheimer’s disease in the communityAnuradha Sehrawat(University of Pittsburgh), Thomas K. Karikari(University of Pittsburgh)medRxivMay 6, 202510.1101/2025.05.03.25326526Cited by 1SaveCiteExport RISWatch citationsRelated PapersBlood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts|The Lancet Neurology|2020|1.3kPittsburgh plasma p‐tau217: Classification accuracies for autosomal dominant and sporadic Alzheimer's disease in the community|Alzheimer s & Dementia|2025|7